Eisai, Halozyme Anounce Collaboration to Investigate Eribulin and Pegph20 in Advanced Breast Cancer
July 31, 2015 at 04:19 AM EDT
Eisai Co., Ltd. (OTC: ESALY) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that they have signed a clinical ...
